Virtual Clinical Trials Are Here: What Now?

Virtual or “siteless” clinical trials allow trial coordinators and patients to conduct clinical study visits via online video calls and collect data via handheld or wearable devices. In addition, virtual trials increase the size and diversity of the patient pool, accelerate recruiting, and generate more informative, clinically-relevant data that is accepted by regulatory agencies. However, moving from traditional to virtual trials presents challenges as clinical trial sponsors learn how to design, execute, and complete effective virtual trials. To assure success, trial sponsors need to better understand the digital tools and platforms used in virtual trials, how to manage the data collection they enable, and the pitfalls to avoid. In this webinar, Bernard Munos, a pioneering pharmaceutical industry innovator, and Transparency Life Sciences co-founder Dr. Tomasz Sablinski will provide an overview of the strategies leaders are finding helpful in adopting and adapting to virtual trials.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

In Situ Bioremediation and In Situ Chemical Reduction for Remediation of 1,2,3-Trichloropropane in Groundwater

siremlab

1,2,3-trichloropropane (TCP) is an emerging groundwater contaminant that is present in widely-used soil fumigants. Individual states have or are in the process of developing regulatory levels for TCP that are as low as 0.0005 micrograms per litre (µg/L). Remedial technologies for TCP that have been implemented at scales ranging from laboratory treatability studies to full-scale field implementation include in situ bioremediation (ISB) and in situ chemical reduction (ISCR).
Watch Now

AlphaLISA and HT-SPR together can help you better understand FcRn biology

Therapeutic discovery and development rely on numerous analytical techniques in order to best position candidate drugs for commercial success. Different analytical technologies are utilized for their respective strengths in maximizing understanding of candidate properties.
Watch Now

BIO 2018 Advanced Partnering Webinar: Partnering Power Tools

bio.org

This webinar is designed for BIO 2018 attendees who are familiar with the BIO One-on-One Partnering™ system and want to use the platform more effectively. Join this advanced partnering webinar—led by BIO’s Director of Partnering—to learn about new system enhancements, commonly overlooked yet powerful features that will help you better identify companies of interest, and more. You can leverage these partnering power tools to take your partnering experience to the next level in Boston.
Watch Now

EXTRACTABLES FROM SINGLE-USE BIOREACTORS/BAGS AND IMPACT ON CELL CULTURE PERFORMANCE

BioPharma Asia Magazine

Attribute Sciences, Process Development, Amgen Biopharmaceuticals are drugs manufactured by growing genetically engineered cells in bioreactors to produce a therapeutic protein. Plastic single-use bioreactors are of interest to biopharmaceutical drug manufacturers due to their significant environmental and cost benefits and flexibility over stainless steel bioreactors. Effect of plastics on the biomanufacturing process is not yet completely understood. A case study on extractables from single-use bioreactors/bags and the impact on cell culture performance will be presented.
Watch Now

Spotlight

resources